Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertise ...

VANCOUVER, BC / ACCESS Newswire / July 7, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:XPHYF)(FSE:4XT), a bioscience innovator specializing in advanced drug delivery systems ...

One of the fundamental barriers to equitable neurological care is the historic male bias in clinical research. For decades, ...

Lindsay Malone, MS, RDN, LD, is a registered dietitian specializing in lifestyle medicine. She works as an integrative and ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

To quantify antibiotics in ICU patients’ blood, dried blood spot analysis was sued alongside UHPLC–MS/MS to monitor these substances in a more convenient matter.

Panelists discuss how robust clinical evidence from major studies like the EPIC and OPERA trials demonstrates that ...

Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving ...

Wendy Chavis Locklear was crowned June 20 as the Senior Ms. Lumbee 2025-2026. Locklear is a native of the Evans Crossing ...